XML 37 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stockholders equity and non-controlling interest
12 Months Ended
Dec. 31, 2011
Stockholders Equity and Noncontrolling Interest [Abstract]  
Stockholders Equity and Noncontrolling Interest [Text Block]
9. Stockholders’ equity and non-controlling interest

 

On March 31, 2010 the Group disposed of all its investments in Medicexchange. During the quarter ended June 30, 2011 the Company disposed of 1.0 million shares of Medicsight via open market sales on London’s AIM Exchange, generating approximately $110 in gross proceeds.  The Company’s overall holding in Medicsight were reduced to 83.75 million shares (53.85%) of the 155.5 million issued share capital of Medicsight.

 

Non-controlling interest

 

The Company has non-controlling investors in Medicsight as follows:

    Medicsight     Medicexchange
(discontinued
operations)
    Total  
                   
Non-controlling interest at December 31, 2009   $ 11,150     $ 254     $ 11,404  
Less non-controlling interest share of net loss     (3,336 )     (14 )     (3,350 )
Non-controlling interest share of stock-based compensation expense     349       3       352  
Non-controlling interest share of other comprehensive income     (202 )     (10 )     (212 )
Disposal of Medicexchange     -       (233 )     (233 )
Non-controlling interest at December 31, 2010   $ 7,961     $     $ 7,961  
                         
Less non-controlling interest share of net loss     (3,006 )           (3,006 )
Non-controlling interest share of stock-based compensation expense     113             113  
Non-controlling interest share of other comprehensive income     128             128  
Increase in non-controlling interest from sale and assignment of Medicsight stock     97             97  
Non-controlling interest at December 31, 2011   $ 5,293     $     $ 5,293  

 

The following schedule presents the effects of changes in MGT’s ownership interest in Medicsight on the equity attributable to MGT:

 

    December 31,  
    2011     2010  
Net loss attributable to MGT Capital Investments, Inc.   $ (4,549 )   $ (9,651 )
Transfers (to) from the non-controlling interest:                
Increase in MGT’s paid in capital from the sale and assignment of Medicsight’s stock     21        
Changes from the net loss attributable to MGT Capital Investments, Inc. and transfers to the  non-controlling interest   $ (4,528 )   $ (9,651 )